DOD
Search
Discussions
Biomedical Jobmarket
News
DOD Alert
Edit DOD
 
ACCOUNT
Login
Register
Forgotten Password?
 
 
Diabetes Open Directory
 
 
Or restrict your search to:
 
Discussion articles  Comments  Journal articles 
Discussions  Availabilities  Job Applications 
Announcements/
Conferences 
Grants/Funds 
 
Information/News 
 
Your search for: 'Zalzman* AND Gupta* AND Giri* AND Berkovich* AND Sappal* AND Karnieli* AND Zern* AND Fleischer* AND Efrat* AND Reversal* AND hyperglycemia* AND mice* AND using* AND human* AND expandable* AND cells* AND differentiated* AND from* AND fetal* AND liver* AND progenitor* AND cells*' Documents 1 - 3 of 3 matches
 

1. (Journal Article): Reversal of hyperglycemia in mice by using human expandable insulin-producing cells differentiated from fetal liver progenitor cells.

Zalzman M, Gupta S, Giri R, Berkovich I, Sappal BS, Karnieli O, Zern MA, Fleischer N, Efrat S
 
ABSTRACT: Beta-cell replacement is considered to be the most promising approach for treatment of type 1 diabetes. Its application on a large scale is hindered by a shortage of cells for tran...

 

 

2. (Journal Article): Reversal of hyperglycemia in mice by using human expandable insulin producing cells differentiated from fetal liver progenitor cells.

Zalzman M, Gupta S, Giri RK, Berkovich I, Sappal BS, Karnieli O, Zern MA, Fleischer N, Efrat S
 
ABSTRACT: Beta-cell replacement is considered to be the most promising approach for treatment of type 1 diabetes. Its application on a large scale is hindered by a shortage of cells for tran...

 

 

3. (Journal Article): Reversal of hyperglycemia in mice by using human expandable insulin producing cells differentiated from fetal liver progenitor cells.

Zalzman M, Gupta S, Giri RK, Berkovich I, Sappal BS, Karnieli O, Zern MA, Fleischer N, Efrat S
 
ABSTRACT: Beta-cell replacement is considered to be the most promising approach for treatment of type 1 diabetes. Its application on a large scale is hindered by a shortage of cells for tran...

 
Result pages:   

1